SCHEMBL118235

SCHEMBL118235

O=C(CCCCCCCCC(=O)OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
MAPK1 P28482 2/20 0.66
L3MBTL1 Q9Y468 2/20 0.66
EPHX2 P34913 1/20 0.56
TDP1 Q9NUW8 2/20 0.55
KMT2A Q03164 2/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
LMNA P02545 2/20 0.53
HTT P42858 1/20 0.51
MAPT P10636 2/20 0.50
RXFP1 Q9HBX9 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
FAAH O00519 1/20 0.49
MGLL Q99685 1/20 0.49
NOTUM Q6P988 1/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49
CDC25B P30305 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27453585 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL20624816 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL10621313 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL28600680 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL2926392 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL10621326 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL28434793 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL4941879 1.00 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL18673 0.98 ALDH1A1 (0.68) ALDH1A1MAPK1L3MBTL1EPHX2TDP1
SCHEMBL3832861 0.96 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1EPHX2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 979 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580751-A2 STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS Adora Animal Health Corporation (US) 2025-07-09 EP claimed
US-12303528-B2 Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions ADORA ANIMAL HEALTH CORPORATION (US) 2025-05-20 US claimed
US-20240342208-A1 STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS ADORA LIFE SCIENCE, INC. 2024-10-17 US claimed
WO-2024072942-A2 SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS ADORA ANIMAL HEALTH CORPORATION (US) 2024-04-04 WO claimed
CN-116355404-A High-crystallinity bio-based semi-aromatic polyamide material and preparation method thereof 中国科学院宁波材料技术与工程研究所 2023-06-30 CN claimed
US-20230147697-A1 TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY BERG, KARA ANN 2023-05-11 US claimed
EP-2459187-B1 COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH OLSEN ELISE (US) 2021-01-06 EP claimed
US-20200330479-A1 COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS THE PROCTER & GAMBLE COMPANY 2020-10-22 US claimed
US-10588859-B2 Topical formulations having enhanced bioavailability BERG LLC (US) 2020-03-17 US claimed
CN-108410399-B A kind of left and right waist patch special glue and preparation method thereof 江苏嘉好热熔胶股份有限公司 2019-10-11 CN claimed
US-4865648-A ELECTRON DONOR DYE; ESTER; PHENOL, CARBOXY ACID, PHOSPHATE ESTER, TRIAZOLE KITO TSUTOMU (JP) 1989-09-12 US claimed
EP-0160726-B1 CONTINUOUS PROCESS FOR PRODUCTION OF BUBBLE GUM NABISCO BRANDS, Inc. (US) 1988-04-20 EP claimed
US-4720301-A Reversible heat sensitive recording composition PILOT INK CO., LTD. (JP) 1988-01-19 US claimed
US-4699940-A POLAR SOLVENTS, PLASTICIZERS, ELASTOMERS PROTECTIVE TREATMENTS, INC. (US) 1987-10-13 US claimed
EP-0160726-A1 Continuous process for production of bubble gum NABISCO BRANDS, Inc. (US) 1985-11-13 EP claimed
US-4525214-A VEGETABLE WAXES, DIPHENYLCARBAZONE COMPLEXING AGENTS, SEBACATE COUPLER THE MAZER CORPORATION (US) 1985-06-25 US claimed
US-4320139-A Method of enhancing the activity of fast evaporating insecticides FUMAKILLA LIMITED (JP) 1982-03-16 US claimed
EP-0006212-B1 SYSTEM OF PULVERISATION IN THE FORM OF AN AEROSOL Airwick AG (CH) 1981-08-05 EP claimed
US-4104444-A POLYETHOXYAMINES, MELAMINE DERIVATIVES HOECHST AKTIENGESELLSCHAFT (DE) 1978-08-01 US claimed
US-3979318-A SODIUM PERBORATE, HYDROPHOBIC LIQUID COATING KAO SOAP CO., LTD. (JA) 1976-09-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200330479-A1 COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS PTGES, PTGS1, PTGS2 ALDH1A1 1460/4885MAPK1 3770/4885L3MBTL1 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.